The plasma levels of interleukin-4 (IL-4), interleukin-2 (IL-2), soluble receptor of IL-2 (IL-2R) and T cell expression of IL-2 receptor chain (CD25+) were determined in an attempt to relate these parameters with disease activity in systemic lupus erythematosus (SLE). IL-4, IL-2 and sIL-2R plasma levels of SLE patients were significantly higher than those of the control group (P<0.05) while CD25+ expression was similar in both groups. Only sIL-2R levels were significantly higher (P<0.05) in active than in inactive patients.
Karray S., Defrance T., Merle-Beral H., Banchereau J., Debre P., Galanaud P.Interleukin 4 counteracts the interleukin-2 induced proliferation of monoclonal B cells. J Exp Med1988; 168: 85-9.
3.
Croft M., Swain SLB cell response to fresh and effector T helper cells: role of cognate T-B interaction and the cytokines IL-2, IL-4 and IL-6. J Immunol1991; 146: 4055-64.
4.
Vazquez A., Auffredou MT, Galanaud P., Leca G.Modulation of IL-2 and IL-4-dependent human B cell proliferation by cyclic AMP. J Immunol1991; 148: 4222-27.
5.
Manoussakis MN, Papadopoulos GK, Drosos AA, Moutsopoulos HMSoluble interleukin-2 receptor molecules in serum of patients with autoimmune diseases . Clin Immunol Immunopathol1989; 50: 321-32.
6.
Gaya A., de la Calle O., Yague J. et al. IL-4 inhibits IL-2 syntesis and IL-2 induced up-regulation of IL-2R but not IL-2 chain in CD4+ human T cells. J Immunol1991; 146: 4209-14.
7.
Tan EM, Cohen AS, Fries J. et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1982; 25: 1277-87.
8.
Liang MH, Stern S., Esdaile J.Systemic lupus erythematosus activity: an operational definition. Rheum Dis Clin North Am1988; 14: 57-66.
9.
Huang YP, Perrin LH, Miescher PA, Zubler RACorrelation of T and B cell activities in vitro and serum IL-2 levels in systemic lupus erythematosus. J Immunol1988; 141: 827-33.
10.
Alcocer Varela J., Alarcon-Segovia D. Decreased production of a response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus. J Clin Invest1982; 69: 1388-92.
11.
Linker-Israeli M., Quismorio FP, Horwitz DAFurther characterization of interleukin-2 production of patients with systemic lupus erythematosus . J Rheumatol1988; 15: 1216-22.
12.
Mckenna RM, Wilkins JA, Warrington RILymphokine production in rheumatoid arthritis and systemic lupus erythematosus . J Rheumatol1988; 15: 1639-42.
13.
Santamaria M. , Marubayashi M., Garcia-Cozar F., Cuadrado MJ, Fernandez-Arcas N., Pena J.Il-2 production via CD28 is conserved in SLE T cells (submitted for publication).
14.
Draeger AM, Swaak AJ, Van-den-Bkink Hg, Aarden LA. T cell function in SLE: normal production of a responsiveness to interleukin-2. Clin Exp Immunol1986; 64: 80-7.
15.
Huang YP, Miescher PA, Zubler RHThe interleukin-2 secretion defect in vitro in systemic lupus erythematosus is reversible in rested cultured T cells. J Immunol1986; 137: 3515-20.
16.
Razziudin S. , Al Janadi MA, Wabell AA. Soluble IL-2 receptor levels in serum and its relationship to T cell abnormality and clinical manifestations of the disease in patients with SLE. J Rheumatol1991 ; 18: 831-6.
17.
Campen DH, Horwitz DA, Quismorio FP et al. Serum levels of interleukin-2 receptor and activity of rheumatic diseases characterized by system immune activation. Arthritis Rheum1990; 31: 1358-64.
18.
Degiannis D. , Seibold J., Czarnecki M., Raskova J., Raska K.Soluble IL-2R in patients with systemic sclerosis . Arthritis Rheum1990; 33: 375-80.
19.
Ishida H., Kumagai S., Umehara H. et al. Impaired expression of high affinity IL-2R on activated lymphocites from patients with SLE. J Immunol1987; 139: 1070-74.
20.
Inghirami G. , Simon J., Ballow JE, Tsokos GCActivated T lymphocytes in the peripheral blood of patients with systemic lupus erythematosus induce B cells to produce immunoglobulin. Clin Exp Rheumatol1988; 6: 269-76.
21.
Bloemena E. , van Oers MH, Weinreich S., Schellekens PTCyclosporine A and prednisolone do not inhibit the expression of high-affinity receptors for IL-2. Clin Exp Immunol1988; 71: 308-13.
22.
Martinez-Cordero E., Alcocer Varela, Alarcon Segovia D.Stimulating and differentiation factors for human B lymphocytes in SLE. Clin Exp Immunol1986; 65: 598-604.
23.
Ueda Y., Sakane T., Tsumematsu T.Hyperreactivity of activated B cells to B cell growth factor in patients with systemic lupus erythematosus. J Immunol1989 ; xx: 3988-93.
